{
    "clinical_study": {
        "@rank": "141192", 
        "biospec_descr": {
            "textblock": "De-identified banked genomic DNA"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "To establish the overall agreement of the MassPLEX Factor II and Factor V Leiden Genotyping\n      Test with bi-directional DNA sequencing for Factor II and Factor V Leiden."
        }, 
        "brief_title": "Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Factor V Leiden", 
            "Factor II", 
            "Thrombosis"
        ], 
        "condition_browse": {
            "mesh_term": "Thrombosis"
        }, 
        "detailed_description": {
            "textblock": "De-identified banked genomic DNA samples derived from whole blood from subjects with\n      suspected thrombophilia will be collected from one or more clinical sites.  Three clinical\n      laboratory sites will analyze the samples with the FII/FVL Test.  Bi-directional DNA\n      sequencing will be performed on all samples at an independent core reference laboratory."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  suspected thrombophilia\n\n          -  18 years of age or older\n\n        Exclusion Criteria:\n\n          -  none"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with suspected thrombophilia"
            }
        }, 
        "enrollment": {
            "#text": "867", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01835483", 
            "org_study_id": "SQNM-FVL-300"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 16, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Grand Rapids", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "49503"
                    }, 
                    "name": "Sequenom Center for Molecular Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97239"
                    }, 
                    "name": "Oregon Health & Science University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "The Methodist Hospital Research Institute"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Multicenter Clinical Study to Determine the Performance Characteristics of the MassPLEX Factor II and Factor V Leiden Genotyping Test in Patients With Suspected Thrombophilia", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Overall percent agreement of the FII/FVL Test results to the bi-directional DNA sequencing results.", 
            "measure": "Performance of the MassPLEX Factor II/V Leiden Test", 
            "safety_issue": "No", 
            "time_frame": "Samples are collected at time of suspected thrombotic event."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01835483"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Sequenom, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sequenom, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}